Ravel Biotechnology
San Francisco, US · 1 known investors
Ravel develops an AI-powered platform for early disease detection by analyzing epigenomic profiles in cell-free DNA to identify cellular destruction markers.
Investors · 1
Frequently asked questions
- What does Ravel Biotechnology do?
- Ravel develops an AI-powered platform for early disease detection by analyzing epigenomic profiles in cell-free DNA to identify cellular destruction markers.
- Who are Ravel Biotechnology's investors?
- Ravel Biotechnology's investors include Hemi Ventures, Llc.
- Where is Ravel Biotechnology headquartered?
- Ravel Biotechnology is headquartered in San Francisco, US.